Literature DB >> 28741171

[Unresectable colorectal liver metastases : Prolonged survival with aggressive local therapy].

O Strobel1, M W Büchler2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28741171     DOI： 10.1007/s00104-017-0486-0

Source DB:  PubMed          Journal:  Chirurg        ISSN： 0009-4722            Impact factor:   0.955


× No keyword cloud information.
  1 in total

1.  mFOLFOXIRI with or without bevacizumab for conversion therapy of RAS/BRAF/PIK3CA mutant unresectable colorectal liver metastases: the FORBES non-randomized phase II trial.

Authors:  Cailu Shen; Huabin Hu; Yue Cai; Jiayu Ling; Jianwei Zhang; Zehua Wu; Xiaoyu Xie; Meijin Huang; Hui Wang; Liang Kang; Ping Lan; Xiaojian Wu; Guangjian Liu; Yunle Wan; Zhiyang Zhou; Yan Huang; Fangqian Li; Huaiming Wang; Tenghui Ma; Shuangling Luo; Yonghua Cai; Lishuo Shi; Yanhong Deng
Journal:  Ann Transl Med       Date:  2022-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.